Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Reversal of multidrug resistance of cancer cells in vitro: modification of drug resistance by selected carotenoids.

Gyémánt N, Tanaka M, Molnár P, Deli J, Mándoky L, Molnár J.

Anticancer Res. 2006 Jan-Feb;26(1A):367-74.

2.

New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.

Molnar J, Mucsi I, Nacsa J, Hevér A, Gyémánt N, Ugocsai K, Hegyes P, Kiessig S, Gaal D, Lage H, Varga A.

Anticancer Res. 2004 Mar-Apr;24(2B):865-71.

3.

Modulation of multidrug resistance and apoptosis of cancer cells by selected carotenoids.

Molnár J, Gyémánt N, Mucsi I, Molnár A, Szabó M, Körtvélyesi T, Varga A, Molnár P, Tóth G.

In Vivo. 2004 Mar-Apr;18(2):237-44.

4.

In vitro search for synergy between flavonoids and epirubicin on multidrug-resistant cancer cells.

Gyémánt N, Tanaka M, Antus S, Hohmann J, Csuka O, Mándoky L, Molnár J.

In Vivo. 2005 Mar-Apr;19(2):367-74.

5.

REIC/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces apoptosis in breast cancer.

Kawasaki K, Watanabe M, Sakaguchi M, Ogasawara Y, Ochiai K, Nasu Y, Doihara H, Kashiwakura Y, Huh NH, Kumon H, Date H.

Cancer Gene Ther. 2009 Jan;16(1):65-72. doi: 10.1038/cgt.2008.58. Epub 2008 Jul 25.

PMID:
18654608
7.
8.

Reversal of multidrug resistance by synthetic and natural compounds in drug-resistant MCF-7 cell lines.

Kars MD, Işeri OD, Gunduz U, Molnar J.

Chemotherapy. 2008;54(3):194-200. doi: 10.1159/000140462. Epub 2008 Jun 18.

PMID:
18560226
9.

MDR-reversal activity of chalcones.

Ivanova A, Batovska D, Engi H, Parushev S, Ocsovszki I, Kostova I, Molnar J.

In Vivo. 2008 May-Jun;22(3):379-84.

10.

Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.

Chang CC, Liang YC, Klutz A, Hsu CI, Lin CF, Mold DE, Chou TC, Lee YC, Huang RC.

Cancer Chemother Pharmacol. 2006 Nov;58(5):640-53. Epub 2006 Mar 17.

PMID:
16544145
11.

Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.

Koo JS, Choi WC, Rhee YH, Lee HJ, Lee EO, Ahn KS, Bae HS, Ahn KS, Kang JM, Choi SU, Kim MO, Lu J, Kim SH.

Life Sci. 2008 Nov 21;83(21-22):700-8. doi: 10.1016/j.lfs.2008.09.009. Epub 2008 Sep 24.

PMID:
18845169
12.

Inhibition of P-glycoprotein transport function by N-acylphenothiazines.

Wesolowska O, Molnár J, Motohashi N, Michalak K.

Anticancer Res. 2002 Sep-Oct;22(5):2863-7.

PMID:
12530010
13.

Inhibition of P-glycoprotein transport activity in a resistant mouse lymphoma cell line by diterpenic lactones.

Ferreira MJ, Gyémánt N, Madureira AM, Molnár J.

Anticancer Res. 2005 Sep-Oct;25(5):3259-62.

14.

Reversal of drug resistance in P-glycoprotein-expressing T-cell acute lymphoblastic CEM leukemia cells by copper N-(2-hydroxy acetophenone) glycinate and oxalyl bis (N-phenyl) hydroxamic acid.

Majumder S, Dutta P, Mukherjee P, Datta ER, Efferth T, Bhattacharya S, Choudhuri SK.

Cancer Lett. 2006 Nov 28;244(1):16-23. Epub 2006 Jan 10.

PMID:
16410038
15.

Time-lapse live cell imaging and flow analysis of multidrug resistance reversal by verapamil in bladder cancer cell lines.

Featherstone JM, Lwaleed BA, Speers AG, Hayes MC, Birch BR, Cooper AJ.

Urology. 2009 Aug;74(2):378-84. doi: 10.1016/j.urology.2009.03.012. Epub 2009 Jun 7.

PMID:
19501884
16.

Combined Fourier transform infrared and Raman spectroscopic approach for identification of multidrug resistance phenotype in cancer cell lines.

Krishna CM, Kegelaer G, Adt I, Rubin S, Kartha VB, Manfait M, Sockalingum GD.

Biopolymers. 2006 Aug 5;82(5):462-70.

PMID:
16493658
17.

Reversal of multidrug resistance in mouse lymphoma cells by phenothiazines.

Molnar J, Molnar A, Mucsi I, Pinter O, Nagy B, Varga A, Motohashi N.

In Vivo. 2003 Mar-Apr;17(2):145-9.

PMID:
12792975
18.

Intravesical pH: a potentially important variable affecting efficacy and the further development of anthracycline chemotherapy for superficial bladder cancer.

Harris NM, Duffy PM, Crook TJ, Anderson WR, Sharpe P, Hayes MC, Cooper AJ, Solomon LZ.

BJU Int. 2002 Dec;90(9):957-64.

19.

Antitumor activity of alkaloids derived from Amaryllidaceae species.

Zupkó I, Réthy B, Hohmann J, Molnár J, Ocsovszki I, Falkay G.

In Vivo. 2009 Jan-Feb;23(1):41-8.

20.

Cinnamylidene ketones as potential modulators of multidrug resistance in mouse lymphoma and human colon cancer cell lines.

Engi H, Gyémánt N, Lóránd T, Lévai A, Ocsovszki I, Molnár J.

In Vivo. 2006 Jan-Feb;20(1):119-24.

Supplemental Content

Support Center